Literature DB >> 11867927

Age-related bone loss: old bone, new facts.

George K Chan1, Gustavo Duque.   

Abstract

The human skeleton serves several functions for the body: support, locomotion, protection of vital organs, and housing of bone marrow. Bone remodeling is the result of the interactions of multiple elements, including osteoblasts, osteoclasts, hormones, growth factors, and cytokines, the end result being the maintenance of the bone architecture and to maintain systemic calcium homeostasis. In early life, a careful balance exists between bone formation by osteoblasts and bone resorption by osteoclasts. With aging, the process of coupled bone formation is affected by the reduction of osteoblast differentiation, activity, and life span which is further potentiated in the perimenopausal years with hormone deprivation and increased osteoclast activity. Age-related bone loss is thus not only a consequence of hormone deprivation, but also the result of changes in bone formation and cell-cell interactions with a unique pathophysiology. In this review, we describe the cellular and metabolic changes associated with aging bone and present recent evidence regarding cell differentiation within the bone marrow. We also consider the mechanism of programmed cell death, apoptosis, as being an important determinant of aging in bone as well as describe possible future interventions to prolong the life span of osteoblasts. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 11867927     DOI: 10.1159/000048929

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  67 in total

Review 1.  Aging and bone.

Authors:  A L Boskey; R Coleman
Journal:  J Dent Res       Date:  2010-10-05       Impact factor: 6.116

2.  Impacts of age and gender on bone marrow profiles of BMP7, BMPRs and Stro-1⁺ cells in patients with total hip replacement.

Authors:  Yi Shen; Weili Wang; Xiaomiao Li; Zude Liu; David C Markel; Weiping Ren
Journal:  Int Orthop       Date:  2011-11-03       Impact factor: 3.075

3.  Bone acquisition in healthy young females is reciprocally related to marrow adiposity.

Authors:  Natascia Di Iorgi; Ashley O Mo; Kate Grimm; Tishya A L Wren; Frederick Dorey; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2010-04-14       Impact factor: 5.958

4.  Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET.

Authors:  Jérôme J Waterval; Thijs M A Van Dongen; Robert J Stokroos; Jaap G J Teule; Gerrit J Kemerink; Boudewijn Brans; Fred H M Nieman; Johannes J Manni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-16       Impact factor: 9.236

5.  Efficient isolation of bone marrow adipocyte progenitors by silica microbeads incubation.

Authors:  Qiqi Lu; Hua Liu; Tong Cao
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

6.  Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation.

Authors:  Xing Zhong; Ling-ling Xiu; Guo-hong Wei; Yuan-yuan Liu; Lei Su; Xiao-pei Cao; Yan-bing Li; Hai-peng Xiao
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

7.  Capacitative calcium entry and proliferation of human osteoblast-like MG-63 cells.

Authors:  D Labelle; C Jumarie; R Moreau
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

Review 8.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

9.  Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults.

Authors:  Natascia Di Iorgi; Michael Rosol; Steven D Mittelman; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

10.  Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.

Authors:  N Maruotti; A Corrado; M Grano; S Colucci; F P Cantatore
Journal:  Rheumatol Int       Date:  2008-11-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.